BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

News Facts: - Aichi Cancer Center and Fujitsu jointly developed new AI solution to support physicians in efficiently choosing medical treatment expected t...

October 19, 2021 | News

Medtronic to invest up to US$50m to advance the future of healthcare technologies in APAC

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the launch of the Medtronic Open Innovation Platform (OIP) ...

October 14, 2021 | News

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

News Facts:- Fujitsu and the University of Tokyo Hospital validate the effectiveness of proprietary AI technology that uses electrocardiographic data...

October 11, 2021 | News

Elixirgen Therapeutics Announces Licensing Agreement for Its Novel COVID-19 Vaccine

it has entered into an exclusive licensing agreement with a global pharmaceutical company (currently undisclosed) for the rights to commercialize its self-...

October 11, 2021 | News

Catalent Opens New Full-Service Clinical Supply Facility in Shiga, Japan

The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and pharmaceutical companies. The facili...

October 10, 2021 | News

Mawi DNA Technologies Announces Partnership with FUJIFILM

“The collaboration with FUJIFILM Wako to provide iSWAB Microbiome-EL sample collection tubes for molecular testing of COVID-19 by PCR and LAMP based ...

October 05, 2021 | News

Japan to Encourages Breakthrough Cancer Research

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...

October 05, 2021 | News

Japan Approves Pfizer’s CIBINQO® to treat Atopic Dermatitis

Pfizer Inc. (NYSE: PFE) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved CIBINQO® (abrocitinib), ...

October 04, 2021 | News

Aptamer Group and BizCom announce collaboration for Optimer distribution and marketing services in Japan

This agreement gives BizCom non-exclusive rights to market and sell Optimer discovery and development services in Japan. The Optimer platform consis...

September 29, 2021 | News

Mirum. Takeda to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Partnership leverages Takeda’s leadership in rare disease, gastroenterology, and hepatology to advance maralixibat in a major market Mirum P...

September 23, 2021 | News

MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study

The study involves 133 patients across 13 centres in Japan. Its objective is to assess the safety and efficacy of SELUTION SLR for the treatment of le...

September 23, 2021 | News

Olympus Strengthens Surgical Portfolio

Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced the launch of the first devices in the new POWERSEAL&tr...

September 21, 2021 | News

AbbVie, Eisai, and EA Pharma Launch "Humira Support Tool Ordering Service for Patients

AbbVie GK, Eisai Co., Ltd., and EA Pharma Co., Ltd. announced today that, on September 13, 2021, the companies launched "Humira Support Tool Ordering Servi...

September 13, 2021 | News

TANAKA Contributes to Ambix Life Science Fund, a U.S. Medical Device Venture Fund

TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku, Tokyo; Representative Director & CEO: Koichiro Tanaka), which is a subsidiary of TANAKA Holdings ...

September 06, 2021 | News

Stay Connected